Sona Nanotech Stock Shares Outstanding

SNANF Stock  USD 0.19  0.01  5.00%   
Sona Nanotech fundamentals help investors to digest information that contributes to Sona Nanotech's financial success or failures. It also enables traders to predict the movement of Sona OTC Stock. The fundamental analysis module provides a way to measure Sona Nanotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sona Nanotech otc stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Sona Nanotech OTC Stock Shares Outstanding Analysis

Sona Nanotech's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Shares Outstanding

 = 

Public Shares

-

Repurchased

More About Shares Outstanding | All Equity Analysis

Current Sona Nanotech Shares Outstanding

    
  68.99 M  
Most of Sona Nanotech's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sona Nanotech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition

Based on the latest financial disclosure, Sona Nanotech has 68.99 M of shares currently outstending. This is 61.79% lower than that of the Healthcare sector and 51.66% lower than that of the Diagnostics & Research industry. The shares outstanding for all United States stocks is 87.94% higher than that of the company.

Sona Shares Outstanding Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sona Nanotech's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Sona Nanotech could also be used in its relative valuation, which is a method of valuing Sona Nanotech by comparing valuation metrics of similar companies.
Sona Nanotech is currently under evaluation in shares outstanding category among its peers.

Sona Fundamentals

About Sona Nanotech Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Sona Nanotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sona Nanotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sona Nanotech based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Sona OTC Stock

Sona Nanotech financial ratios help investors to determine whether Sona OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sona with respect to the benefits of owning Sona Nanotech security.